|
|||||
|
|
Identification of targets for prostate cancer immunotherapy |
|
| Authors: | Antonios Papanicolau-Sengos MD MS Yuanquan Yang MD PhD Sarabjot Pabla PhD Felicia L. Lenzo PhD Shumei Kato MD Razelle Kurzrock MD Paul DePietro PhD Mary Nesline MS Jeffrey Conroy BS Sean Glenn PhD Gurkamal Chatta MD Carl Morrison MD DVM |
| Affiliation: | 1. OmniSeq, Inc., Buffalo, New York;2. Roswell Park Comprehensive Cancer Center, Buffalo, New York;3. Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, California;4. OmniSeq, Inc., Buffalo, New York Roswell Park Comprehensive Cancer Center, Buffalo, New York |
| Abstract: | |
| Keywords: | aggressive prostate cancer castration-resistant prostate cancer castration-sensitive prostate cancer CD226 CD276 immunotherapy NECTIN2 PVR TIGIT |